Gilpin Wealth Management’s Pediatrix Medical MD Stock Holding History

Gilpin Wealth Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$309	Hold	12	–	–	﹤0.01%	997
2026 Q2	$304	Buy	12 +2	+20%	+$46	﹤0.01%	825
2026 Q1	$214	Hold	10	–	–	﹤0.01%	842
2025 Q4	$214	Buy	+10	New	+$205	﹤0.01%	642

Other funds holding MD

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

DCM

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Gilpin Wealth Management's MD Position: Q3 2026 in Review

Gilpin Wealth Management held its Pediatrix Medical (MD) position steady in Q3 2026 at 12 shares worth $309. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Gilpin Wealth Management first reported a position in MD in Q4 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold MD as of Q3 2026.

Gilpin Wealth Management held 12 shares of Pediatrix Medical worth $309 as of Q3 2026.
Gilpin Wealth Management left its Pediatrix Medical share count unchanged in Q3 2026.
Pediatrix Medical made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #997 holding.
Gilpin Wealth Management first reported a position in Pediatrix Medical in Q4 2025 and has held it in 4 quarters since.
6 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.